We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+2.5%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$228B
AUM Growth
+$29.9B
Cap. Flow
+$21.5B
Cap. Flow %
9.45%
Top 10 Hldgs %
22.25%
Holding
10,525
New
1,702
Increased
3,804
Reduced
3,457
Closed
1,419

Sector Composition

Rank Sector Weight
1 Technology 2.03%
2 Consumer Discretionary 1.46%
3 Financials 1.01%
4 Healthcare 0.92%
5 Communication Services 0.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNSY
8951
CALL
Cerenome
CNSY
$23M
0
SB icon
8952
PUT
Safe Bulkers
SB
$848M
$28K ﹤0.01%
12,400
-7,100
-36% -$15.6K
ARQL
8953
CALL
DELISTED
Arqule Inc
ARQL
$28K ﹤0.01%
22,400
+10,000
+81% +$10.9K
BIOA
8954
DELISTED
BioAmber Inc.
BIOA
$28K ﹤0.01%
+10,991
New +$25.3K
TDW icon
8955
PUT
Tidewater
TDW
$4.44B
$27K ﹤0.01%
1,178
+505
+75% +$13.6K
VIRX
8956
PUT
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$27K ﹤0.01%
+286
New +$32.8K
AMPE
8957
CALL
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$26K ﹤0.01%
168
+80
+91% +$16.2K
HLTH
8958
PUT
DELISTED
Nobilis Health Corp.
HLTH
$26K ﹤0.01%
13,800
-3,000
-18% -$4.54K
NAVB
8959
PUT
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$26K ﹤0.01%
2,555
-895
-26% -$8.85K
MATR
8960
PUT
DELISTED
Mattersight Corp.
MATR
$26K ﹤0.01%
10,100
-15,600
-61% -$45.5K
NCTY
8961
The9 Ltd
NCTY
$68.1M
$25K ﹤0.01%
+72
New +$22.6K
NEON icon
8962
Neonode
NEON
$15.1M
$25K ﹤0.01%
2,314
+211
+10% +$2.87K
TGB
8963
PUT
Trekor Metals
TGB
$3.42B
$25K ﹤0.01%
+19,600
New +$23.7K
PRKR
8964
DELISTED
Parkervision Inc
PRKR
$25K ﹤0.01%
+13,819
New +$29.5K
ERN
8965
DELISTED
Erin Energy Corp
ERN
$25K ﹤0.01%
17,404
+3,124
+22% +$5.76K
INFU icon
8966
InfuSystem Holdings
INFU
$239M
$24K ﹤0.01%
+13,886
New +$25K
BPTH
8967
DELISTED
Bio-Path Holdings Inc
BPTH
$24K ﹤0.01%
+16
New +$33.5K
SCON
8968
DELISTED
Superconductor Technologies Inc.
SCON
$24K ﹤0.01%
+139
New +$24.5K
VRML
8969
CALL
DELISTED
Vermillion, Inc.
VRML
$24K ﹤0.01%
12,900
-9,800
-43% -$17.9K
NIHD
8970
PUT
DELISTED
NII Holdings, Inc. Common Stock
NIHD
$24K ﹤0.01%
30,000
-22,200
-43% -$17K
SCYX icon
8971
SCYNEXIS
SCYX
$54M
$23K ﹤0.01%
161
-267
-62% -$44.3K
BSIN
8972
Big Sky Industrial
BSIN
$80.3M
$23K ﹤0.01%
+3,308
New +$27.5K
GEN
8973
DELISTED
Genesis Healthcare, Inc.
GEN
$23K ﹤0.01%
+13,313
New +$28.3K
CXRX
8974
DELISTED
Concordia International Corp. Common Stock
CXRX
$23K ﹤0.01%
+14,847
New +$20.2K
XRA
8975
CALL
DELISTED
Exeter Resources Corporation
XRA
$23K ﹤0.01%
15,200

Similar funds

Jeff Yass's Q2 2017 Portfolio in Review

As of Q2 2017, Jeff Yass held 10,525 positions worth $228B, up 15% from $198B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Jeff Yass deployed $21.5B of net new capital in Q2 2017, opening 1,702 new positions and adding to 3,804 existing holdings. Its largest new stake was Altaba Inc: 9,835,232 shares worth $536M.

By sector, the portfolio is most concentrated in Technology at 2% of assets, up from 1.2% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $353M trimmed.

  • Jeff Yass's largest Q2 2017 buy was Altaba Inc: 9,835,232 shares worth $536M.
  • Jeff Yass added most to Apple in Q2 2017, an estimated $781M increase.
  • Jeff Yass's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $353M.
  • Jeff Yass fully exited Alphabet (Google) Class C in Q2 2017, selling an estimated $261M.
  • Jeff Yass's ten largest holdings make up 22% of its $228B portfolio in Q2 2017.
  • Jeff Yass opened 1,702 new positions and closed 1,419 in Q2 2017.
  • Jeff Yass's portfolio value rose 15% quarter-over-quarter to $228B.

Based on Susquehanna International Group's 13F filing for Q2 2017, filed 15 Aug 2017.